Northwestern Mutual Wealth Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-437
Closed -$7K 2548
2016
Q4
$7K Buy
+437
New +$5.77K ﹤0.01% 1756
2016
Q3
Sell
-437
Closed -$5K 1751
2016
Q2
$5K Buy
437
+54
+14% +$557 ﹤0.01% 1618
2016
Q1
$4K Buy
+383
New +$4.12K ﹤0.01% 1755
2015
Q2
Sell
-660
Closed -$10K 1702
2015
Q1
$10K Hold
660
﹤0.01% 1048
2014
Q4
$8K Hold
660
﹤0.01% 1162
2014
Q3
$7K Hold
660
﹤0.01% 989
2014
Q2
$8K Buy
660
+460
+230% +$5.43K ﹤0.01% 939
2014
Q1
$2K Hold
200
﹤0.01% 1164
2013
Q4
$4K Buy
+200
New +$3.36K ﹤0.01% 1130

Other funds holding MNTA

Northwestern Mutual Wealth Management's MNTA Position: Q1 2017 in Review

Northwestern Mutual Wealth Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2017, closing a stake of 437 shares — an estimated $7K sold.

Northwestern Mutual Wealth Management first reported a position in MNTA in Q4 2013 and held it in 9 quarters. The position peaked at $10K in Q1 2015. 162 funds tracked by Wall St. Rank hold MNTA as of Q1 2017.

  • Northwestern Mutual Wealth Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 437 Momenta Pharmaceuticals, Inc. shares in Q1 2017, an estimated $7K.
  • Northwestern Mutual Wealth Management first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2013 and held it in 9 quarters.
  • Northwestern Mutual Wealth Management's Momenta Pharmaceuticals, Inc. position peaked at $10K in Q1 2015.
  • 162 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2017.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2017, filed 9 May 2017.